AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19453893 — intervention group
Group type: COMPARATOR
Intervention: Tadalafil 20 mg (as historical control)
Number of subjects: 0
Study 17966178 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL, 600-850 nm)
Number of subjects: 22
Study 17966178 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of IPL (580-980 nm) and bipolar radiofrequency (RF) energies
Number of subjects: 22
Study 17966178 — intervention group
Group type: COMPARATOR
Intervention: Blue light (417 nm)
Number of subjects: 22
Study 15166572 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 20 mM
Number of subjects: 9
Study 15166572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 4 mM
Number of subjects: 9
Study 15166572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 11322868 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 0
Study 9831637 — intervention group
Group type: EXPERIMENTAL
Intervention: Normocholesterolemic patients with primary biliary cirrhosis
Number of subjects: 25
Study 9831637 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic patients with primary biliary cirrhosis
Number of subjects: 25
Study 9831637 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with primary biliary cirrhosis
Number of subjects: 25
Study 7906386 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of zidovudine per day
Number of subjects: 1338
Study 7906386 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg of zidovudine per day
Number of subjects: 1338
Study 7906386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1338
Study 2780003 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha‐1‐isopropyl ester (0.5 microgram)
Number of subjects: 24
Study 2780003 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha‐1‐isopropyl ester (0.25 microgram)
Number of subjects: 24
Study 2780003 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 24
Study 2780003 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha‐1‐isopropyl ester
Number of subjects: 24
Study 2780003 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha‐1‐isopropyl ester and Vehicle
Number of subjects: 24
Study 961922 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana
Number of subjects: 0
Study 961922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31608939 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic McKeown esophagectomy (RME)
Number of subjects: 652
Study 31608939 — intervention group
Group type: COMPARATOR
Intervention: Thoraco-laparoscopic McKeown esophagectomy (TLME)
Number of subjects: 652
Study 31406013 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based outpatient early palliative care (TO-EPC)
Number of subjects: 0
Study 27746408 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 18
Study 27746408 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 18
Study 25803346 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon-expandable stent plus medical therapy (stent group; n=59)
Number of subjects: 112
Study 25803346 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone (medical group; n=53)
Number of subjects: 112
Study 23610518 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger men
Number of subjects: 12
Study 23610518 — intervention group
Group type: COMPARATOR
Intervention: Older men
Number of subjects: 12
Study 21334564 — intervention group
Group type: EXPERIMENTAL
Intervention: New cognitive‐behaviorally based parenting intervention (10 sessions, group format)
Number of subjects: 74
Study 21334564 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 74
Study 19812684 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic bronchitis
Number of subjects: 1934
Study 19812684 — intervention group
Group type: EXPERIMENTAL
Intervention: Emphysema
Number of subjects: 1934
Study 19812684 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD
Number of subjects: 1934
Study 19812684 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma
Number of subjects: 1934
Study 17223985 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone at a dose of 2.5‐7.5 mg/day
Number of subjects: 8
Study 17223985 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 8
Study 15080514 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Hydroxy Indole Acetic Acid (5-HIAA) measurement in spot urine
Number of subjects: 26
Study 15080514 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients prepared for hernia repair)
Number of subjects: 26
Study 15080514 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HIAA measurement in patients with gangrenous appendicitis
Number of subjects: 26
Study 15080514 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HIAA measurement in patients without histopathological gangrenous changes
Number of subjects: 26
Study 11808764 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride solution (44,800 ppm F) applied annually
Number of subjects: 375
Study 11808764 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride solution (44,800 ppm F) with soft carious tissue removal applied annually
Number of subjects: 375
Study 11808764 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF varnish (22,600 ppm F) applied every three months
Number of subjects: 375
Study 11808764 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF varnish (22,600 ppm F) with soft carious tissue removal applied every three months
Number of subjects: 375
Study 11808764 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 375
Study 9555445 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-applied breathing and guided imagery relaxation techniques, separately and in combination, and a reinforcement tool
Number of subjects: 20
Study 9555445 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 20
Study 7989469 — intervention group
Group type: EXPERIMENTAL
Intervention: Black subjects
Number of subjects: 12
Study 7989469 — intervention group
Group type: COMPARATOR
Intervention: White subjects
Number of subjects: 12
Study 3142243 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (n = 41)
Number of subjects: 66
Study 3142243 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 66
Study 31268131 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 40
Study 31268131 — intervention group
Group type: EXPERIMENTAL
Intervention: TRF plus 3 g/d HMB (TRFHMB)
Number of subjects: 40
Study 31268131 — intervention group
Group type: COMPARATOR
Intervention: Control diet (CD)
Number of subjects: 40
Study 31268131 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (TRF, TRFHMB, CD)
Number of subjects: 40
Study 28830632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention from two randomized controlled trials
Number of subjects: 0
Study 27036112 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief advisory session plus measuring exhaled CO
Number of subjects: 112
Study 27036112 — intervention group
Group type: COMPARATOR
Intervention: Brief advisory session
Number of subjects: 112
Study 25449504 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 mg adenosine (ADO)
Number of subjects: 201
Study 25449504 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 201
Study 23575051 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Tranexamic Acid (250 mg twice a day for three months)
Number of subjects: 260
Study 23575051 — intervention group
Group type: COMPARATOR
Intervention: Routine topical therapies
Number of subjects: 260
Study 19531111 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive interpersonal psychotherapy for depressed adolescents with suicidal risk (IPT‐A‐IN)
Number of subjects: 73
Study 19531111 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 73
Study 17311685 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention using postcards and posters on depression and its treatment
Number of subjects: 3313
Study 17311685 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3313
Study 14756643 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm PDL at fluence 15 J/cm2 (1.5 ms)
Number of subjects: 22
Study 14756643 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm PDL at fluence 15 J/cm2 (10 ms)
Number of subjects: 22
Study 14756643 — intervention group
Group type: EXPERIMENTAL
Intervention: 532-nm Nd:YAG laser at 2 ms, 7 J/cm2
Number of subjects: 22
Study 14756643 — intervention group
Group type: EXPERIMENTAL
Intervention: 532-nm Nd:YAG laser at 10 ms, 16 J/cm2
Number of subjects: 22
Study 14756643 — intervention group
Group type: COMPARATOR
Intervention: 585-nm 0.45-ms PDL (control area)
Number of subjects: 22
Study 11453905 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 26
Study 11453905 — intervention group
Group type: COMPARATOR
Intervention: Control (Betamethasone valerate or common base)
Number of subjects: 26
Study 9543445 — intervention group
Group type: EXPERIMENTAL
Intervention: gp160 in alum over a 2‐year period in combination with placebo (n = 32)
Number of subjects: 99
Study 9543445 — intervention group
Group type: EXPERIMENTAL
Intervention: gp160 in alum over a 2‐year period in combination with zidovudine (n = 34)
Number of subjects: 99
Study 9543445 — intervention group
Group type: COMPARATOR
Intervention: alum over a 2‐year period in combination with zidovudine (n = 33)
Number of subjects: 99
Study 8066108 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound/Ultraviolet-C (US/UVC) treatment
Number of subjects: 20
Study 8066108 — intervention group
Group type: COMPARATOR
Intervention: Laser treatment
Number of subjects: 20
Study 8066108 — intervention group
Group type: COMPARATOR
Intervention: Nursing care alone
Number of subjects: 20
Study 3143277 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil (60 mg orally thrice a day)
Number of subjects: 12
Study 3143277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30576539 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotrophins
Number of subjects: 666
Study 30576539 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 666
Study 30576539 — intervention group
Group type: EXPERIMENTAL
Intervention: IUI
Number of subjects: 666
Study 30576539 — intervention group
Group type: COMPARATOR
Intervention: Intercourse
Number of subjects: 666
Study 28438185 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional moxibustion (n=69)
Number of subjects: 138
Study 28438185 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-free moxibustion (n=69)
Number of subjects: 138
Study 25328886 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise training for 4 months
Number of subjects: 21
Study 25328886 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise training
Number of subjects: 21
Study 23529632 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive technique
Number of subjects: 40
Study 23529632 — intervention group
Group type: COMPARATOR
Intervention: Conventional open surgery using K wires
Number of subjects: 40
Study 20528706 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help (internet-based)
Number of subjects: 0
Study 20528706 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care model (including watchful waiting, guided self-help, brief psychotherapy, longer-term psychotherapy, and antidepressant medication)
Number of subjects: 0
Study 20528706 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchful waiting
Number of subjects: 0
Study 20528706 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief face-to-face psychotherapy
Number of subjects: 0
Study 20528706 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer-term face-to-face psychotherapy and antidepressant medication
Number of subjects: 0
Study 17663986 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial task
Number of subjects: 0
Study 17663986 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal shadowing task
Number of subjects: 0
Study 17663986 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidental learning
Number of subjects: 0
Study 17663986 — intervention group
Group type: EXPERIMENTAL
Intervention: Room size larger than used by Hermer‐Vazquez et al.
Number of subjects: 0
Study 16160875 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (1 ml/kg)
Number of subjects: 64
Study 16160875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 12648863 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (4.0 g loading dose over 30 min, followed by 1-2 g/hour continuous infusion for up to 21 days)
Number of subjects: 0
Study 12648863 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 0
Study 10808727 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM)
Number of subjects: 0
Study 10808727 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential adverse influences of EBM
Number of subjects: 0
Study 10808727 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential misuse of statistical methods
Number of subjects: 0
Study 8698279 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea drinking (6 mugs of tea daily for 4 weeks)
Number of subjects: 65
Study 8698279 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched intakes of milk, sugar, water, and caffeine for 4 weeks)
Number of subjects: 65
Study 8381935 — intervention group
Group type: EXPERIMENTAL
Intervention: High-permeability modified cellulose membrane (Hemophan-HP)
Number of subjects: 0
Study 8381935 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly(ethylene-co-vinyl alcohol) (EVAL)
Number of subjects: 0
Study 8381935 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly(acrylonitrile-co-sodium methallyl sulphonate) (AN69)
Number of subjects: 0
Study 8381935 — intervention group
Group type: COMPARATOR
Intervention: Cuprophan
Number of subjects: 0
Study 3529153 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (calcium antagonist) at doses of 320-480 mg/day
Number of subjects: 8
Study 3529153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 29661674 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltoid ligament repair with suture anchor
Number of subjects: 59
Study 29661674 — intervention group
Group type: COMPARATOR
Intervention: Syndesmosis screw fixation
Number of subjects: 59
Study 25370731 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 0
Study 25370731 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine
Number of subjects: 0
Study 22687558 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stimulation (LH anodal/RH cathodal)
Number of subjects: 0
Study 22687558 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stimulation (RH anodal/LH Cathodal)
Number of subjects: 0
Study 22687558 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 20458545 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss program (Phase 1)
Number of subjects: 87
Study 20458545 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight maintenance approaches (Phase 2)
Number of subjects: 87
Study 17493509 — intervention group
Group type: EXPERIMENTAL
Intervention: M. charantia capsules (two capsules three times a day after meals for 3 months)
Number of subjects: 40
Study 17493509 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two capsules three times a day after meals for 3 months)
Number of subjects: 40
Study 17493509 — intervention group
Group type: EXPERIMENTAL
Intervention: M. charantia capsules
Number of subjects: 40
Study 16173223 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg/kg
Number of subjects: 13
Study 16173223 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 0.3 mg/kg
Number of subjects: 13
Study 12132548 — intervention group
Group type: EXPERIMENTAL
Intervention: Learner-centred educational project in end-of-life care
Number of subjects: 100
Study 12132548 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 10792471 — intervention group
Group type: EXPERIMENTAL
Intervention: Koate(R)‐DVI (heat‐treated preparation)
Number of subjects: 54
Study 10792471 — intervention group
Group type: COMPARATOR
Intervention: Koate(R)‐HP (unheated preparation)
Number of subjects: 54
Study 8543748 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of furosemide
Number of subjects: 10
Study 8543748 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of furosemide
Number of subjects: 10
Study 8543748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2720135 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg nitrofurantoin tablet
Number of subjects: 14
Study 2720135 — intervention group
Group type: EXPERIMENTAL
Intervention: USP Apparatus 1 at 100 rev min‐1 with pH 7.2 fluid at 30 min
Number of subjects: 14
Study 794000 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoprofen 600 mg daily for 7 days
Number of subjects: 39
Study 794000 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 900 mg daily for 7 days
Number of subjects: 39
Study 31474439 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegcetacoplan monthly
Number of subjects: 246
Study 31474439 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegcetacoplan every other month (EOM)
Number of subjects: 246
Study 31474439 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegcetacoplan EOM
Number of subjects: 246
Study 31474439 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 246
Study 31624047 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD treatment (cyclophosphamide, bortezomib, and dexamethasone)
Number of subjects: 583
Study 31624047 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 583
Study 29239658 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 sessions of adaptive, process-based working memory training
Number of subjects: 142
Study 29239658 — intervention group
Group type: COMPARATOR
Intervention: Active, adaptive visual search control group
Number of subjects: 142
Study 24993395 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry capsules (72 mg proanthocyanidins)
Number of subjects: 41
Study 22869158 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser with radial firing tips (RFT) - RFT2 (140 μs, 37.5 mJ, 20 Hz) and RFT3 (140 μs, 62.5 mJ, 20 Hz) used in the second appointment, moving at 2 mm s(‐1) from apical to coronal.
Number of subjects: 29
Study 22869158 — intervention group
Group type: COMPARATOR
Intervention: 3% sodium hypochlorite and calcium hydroxide as inter-appointment dressing.
Number of subjects: 29
Study 21732195 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient+physician intensive group
Number of subjects: 279
Study 21732195 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician communication skills training and patient coaching by community health workers
Number of subjects: 279
Study 21732195 — intervention group
Group type: COMPARATOR
Intervention: Patient+physician minimal group
Number of subjects: 279
Study 21732195 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician intensive/patient minimal group
Number of subjects: 279
Study 21732195 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient intensive/physician minimal group
Number of subjects: 279
Study 20086317 — intervention group
Group type: EXPERIMENTAL
Intervention: Broccoli with mayonnaise (MS)
Number of subjects: 18
Study 20086317 — intervention group
Group type: EXPERIMENTAL
Intervention: Broccoli with oil (OIL)
Number of subjects: 18
Study 20086317 — intervention group
Group type: COMPARATOR
Intervention: Broccoli (CON)
Number of subjects: 18
Study 20086317 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental areas under the curves (IAUCs) after MS meal
Number of subjects: 18
Study 20086317 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental areas under the curves (IAUCs) after OIL meal
Number of subjects: 18
Study 16498057 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg daily for 12 weeks)
Number of subjects: 99
Study 16498057 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 99
Study 15487957 — intervention group
Group type: EXPERIMENTAL
Intervention: Electoral Roll (ER) arm
Number of subjects: 881
Study 15487957 — intervention group
Group type: COMPARATOR
Intervention: General Practice (GP) arm
Number of subjects: 881
Study 15487957 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 881
Study 10890310 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced mixture of amino acids (B)
Number of subjects: 12
Study 10890310 — intervention group
Group type: COMPARATOR
Intervention: Devoid of tryptophan (T‐)
Number of subjects: 12
Study 9179454 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone-releasing vaginal ring
Number of subjects: 1536
Study 9179454 — intervention group
Group type: COMPARATOR
Intervention: Copper T 380A IUD
Number of subjects: 1536
Study 9179454 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 1536
Study 8299662 — intervention group
Group type: EXPERIMENTAL
Intervention: CL284,846 (20 mg)
Number of subjects: 12
Study 8299662 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 12
Study 8299662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3670870 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-form McGill Pain Questionnaire (SF-MPQ)
Number of subjects: 0
Study 3670870 — intervention group
Group type: COMPARATOR
Intervention: Standard McGill Pain Questionnaire (MPQ)
Number of subjects: 0
Study 28990122 — intervention group
Group type: EXPERIMENTAL
Intervention: fluoridated toothpaste + flossing + infiltration
Number of subjects: 50
Study 28990122 — intervention group
Group type: COMPARATOR
Intervention: fluoridated toothpaste + flossing
Number of subjects: 50